Genetic testing in Parkinson disease-who should be assessed?

Christine Klein; Ana Djarmati

doi:10.1038/nrneurol.2010.197

Genetic testing in Parkinson disease-who should be assessed?

Christine Klein^*, Ana Djarmati

^*Corresponding author for this work

6 Citations (Scopus)

Abstract

Mutations in six genes have been unequivocally linked to Parkinson disease (PD). A recent study found that among 953 patients with the early-onset form of PD, ≈17% harbored a mutation in one of these genes. This finding raises important issues concerning genetic testing and genetic counseling for early-onset PD.

Original language	English
Journal	Nature Reviews Neurology
Volume	7
Issue number	1
Pages (from-to)	7-9
Number of pages	3
ISSN	1759-4758
DOIs	https://doi.org/10.1038/nrneurol.2010.197
Publication status	Published - 01.01.2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 10 Reduced Inequalities

Research Areas and Centers

Research Area: Medical Genetics

Access to Document

10.1038/nrneurol.2010.197

Cite this

@article{8c7c6025898c4a3791a71e9e8784e8b3,

title = "Genetic testing in Parkinson disease-who should be assessed?",

abstract = "Mutations in six genes have been unequivocally linked to Parkinson disease (PD). A recent study found that among 953 patients with the early-onset form of PD, ≈17\% harbored a mutation in one of these genes. This finding raises important issues concerning genetic testing and genetic counseling for early-onset PD. ",

author = "Christine Klein and Ana Djarmati",

year = "2011",

month = jan,

day = "1",

doi = "10.1038/nrneurol.2010.197",

language = "English",

volume = "7",

pages = "7--9",

journal = "Nature Reviews Neurology",

issn = "1759-4758",